Publications & Scientific Presentations

Scientific Presentations

  • March 1, 2024
Enhanced Drug Delivery for Cardiac Microvascular Obstruction with an Occlusion-Infusion-Catheter
YANNICK ROSCH et al.
View Presentation
  • March 1, 2024
Microvascular Obstruction: Real Time Catheter Based Detection and Treatment in the Cath Lab
Robert Schwartz MD FACC,FFSCCT
View Presentation
  • 2023
Novel Methods to Assess Coronary Microvascular Function

Rob Schwartz MD

View Presentation
  • December 4 - 6, 2022
Catheter-Based Microvascular Obstruction Detection Analysis in STEMI: Now a Reality

Jonathan G. Schwartz, MD, FACC, FSCAI
Medical Director, Interventional Cardiology
Clinical Assistant Professor of Medicine
Sanger Heart & Vascular Institute

Atrium Health | Wake Forest SOM | Charlotte, NC, USA

View Presentation
  • December 4 - 6, 2022
MVO Therapy: How and Why have we Failed? Promising New Options

Martin T. Rothman

View Presentation
  • March 1, 2024
Enhanced Drug Delivery for Cardiac Microvascular Obstruction with an Occlusion-Infusion-Catheter
YANNICK ROSCH et al.
View Presentation
  • March 1, 2024
Microvascular Obstruction: Real Time Catheter Based Detection and Treatment in the Cath Lab

Robert Schwartz MD FACC,FFSCCT

View Presentation
  • 2023
Novel Methods to Assess Coronary Microvascular Function

Rob Schwartz MD

View Presentation
  • December 4 - 6, 2022
Catheter-Based Microvascular Obstruction Detection Analysis in STEMI: Now a Reality

Jonathan G. Schwartz, MD, FACC, FSCAI
Medical Director, Interventional Cardiology
Clinical Assistant Professor of Medicine
Sanger Heart & Vascular Institute

Atrium Health | Wake Forest SOM | Charlotte, NC, USA

View Presentation
  • December 4 - 6, 2022
MVO Therapy: How and Why have we Failed? Promising New Options

Martin T. Rothman

View Presentation

CorFlow is developing a medical device that will be the first to diagnose MVO in real-time during PCI and serve as a treatment platform in the cath lab.

Twitter Linkedin
Who we are
Clinical
News
Our Office
  • +41 41 399 18 00
  • CorFlow Therapeutics AG Neuhofstrasse 3d 6340 Baar, Switzerland
  • contact@corflow.ch

The CoFI-System is not approved in the United States of America.  It is an investigational device limited by federal law to investigational use and is not available for commercial distribution.

VAT:CHE 320.873.257 MWST

© 2023 Corflow. All Rights Reserved.

Cookie Policy | Privacy Policy | Site Map | Impressum